CAJAL THERAPEUTICS
Live / Allowed — Notice of allowance issued (as of 24 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 06 Jun 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99222350
- Mark type
- Stylized text
- Filed
- 06 Jun 2025
- Published for opposition
- 30 Dec 2025
- Attorney of record
- Alyssa M. Worsham
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of viral, metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hematological, hepatological, ophthalmic, cardiometabolic, pulmonary, nephrological, respiratory, neurological, neuromuscular, gastrointestinal, hormonal, dermatological, psychiatric, and sexually transmitted diseases, conditions, and disorders.
- Class 042 — Scientific and technological services: Pharmaceutical research and development; drug discovery services; medical and scientific research.
Owner
- Cajal Therapeutics Inc., Seattle, WA, US
- Cajal Therapeutics Inc., Seattle, WA, US
Prosecution history
- 24 Feb 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 30 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Dec 2025 — PUBLISHED FOR OPPOSITION
- 24 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Dec 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 31 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 31 Oct 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 31 Oct 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 28 Oct 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 28 Oct 2025 — NON-FINAL ACTION E-MAILED
- 28 Oct 2025 — NON-FINAL ACTION WRITTEN
- 28 Oct 2025 — ASSIGNED TO EXAMINER
- 14 Oct 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 06 Jun 2025 — APPLICATION FILING RECEIPT MAILED
- 06 Jun 2025 — NEW APPLICATION ENTERED